Prospective Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Nov 21, 2021; 27(43): 7563-7571
Published online Nov 21, 2021. doi: 10.3748/wjg.v27.i43.7563
Table 1 Baseline characteristics, n (%)

Overall
CH
SGH
P value
Patients26160201-
Regions0.07
European60 (23.0)55 (91.7)5 (2.5)
Asian197 (75.5)2 (3.3)195 (97.5)
Others4 (1.5)3 (5.5)1 (0.5)
Age, mean ± SD53 ± 12.952.9 ± 16.953 ± 11.70.30
Male 51.9%53.3%51.7%0.83
ALT, mean ± SD112.3 ± 373.980.2 ± 66.6121.9 ± 425.50.45
AST, mean ± SD80.3 ± 216.760.8 ± 42.386.1 ± 246.10.43
NAS, Median (IQR)4 (3-5)4 (3-5)4 (3-5)0.54
Metavir Fibrosis score, mean ± SD1.7 ± 1.41.6 ± 1.41.7 ± 1.30.58
F053 (20.3)13 (21.7)40 (19.9)
F195 (36.3)25 (41.7)70 (34.8)
F231 (11.9)5 (8.3)26 (12.9)
F348 (18.4)7 (11.7)41 (20.4)
F434 (13.1)10 (16.6)24 (11.9)